Sign in

Amcor (AMCR)

Earnings summaries and quarterly performance for Amcor.

Research analysts who have asked questions during Amcor earnings calls.

Recent press releases and 8-K filings for AMCR.

Amcor issues €1.5B in senior unsecured notes
AMCR
Debt Issuance
  • €750 million 3.200% senior notes due 2029 and €750 million 3.750% senior notes due 2033 issued by Amcor UK Finance plc, fully guaranteed by Amcor plc and affiliates.
  • Net proceeds of approximately €1,488 million to repay Berry Global’s $1.525 billion 1.570% senior secured notes due 2026, with remainder for commercial paper and general corporate purposes.
  • 2029 Notes pay interest annually on November 17 (first coupon November 17, 2026) and mature November 17, 2029; 2033 Notes pay annually on February 20 (short first coupon February 20, 2026) and mature February 20, 2033.
  • Notes are senior unsecured obligations with make-whole redemption at comparable government bond rate + 20 bps before par call dates (October 17, 2029 for 2029 Notes; November 20, 2032 for 2033 Notes) and callable at 100% thereafter.
5 days ago
Amcor reports Q1 FY2026 results
AMCR
Earnings
Guidance Update
Dividends
  • Amcor delivered Net Sales of $5,745 million (+68%), EBITDA of $909 million (+92%) and EPS of 19.3 cents (+18%) in Q1 FY2026.
  • Berry acquisition synergies: $38 million realized in Q1; on track for $260 million in FY2026 and $650 million total.
  • Free Cash Flow of $(343) million in Q1 (including $115 million integration costs); as of September 30 2025, Net Debt $13,999 million and Leverage 3.6×.
  • Reaffirmed FY2026 outlook: Adjusted EPS of $0.80–0.83 per share, Free Cash Flow of $1.8–1.9 billion; dividend increased to 13.0 cents per share.
Nov 5, 2025, 10:30 PM
Amcor reports Q1 2026 earnings results
AMCR
Earnings
Guidance Update
CFO Change
  • Adjusted EPS of $0.193 (up 18% cc) and EBIT of $687 million (+4% cc), with a 12% reported margin (+110 bps y/y)
  • Delivered $38 million in synergies in Q1, on track for $260 million in FY 2026 and $650 million through FY 2028
  • Flexible packaging net sales rose 25% cc (comparable volume down 2.8%), with adjusted EBIT of $426 million and margin of 13.1% (+20 bps)
  • Board approved a quarterly dividend increase to $0.13 per share and reaffirmed guidance for 12–17% EPS growth and doubling free cash flow in FY 2026
  • CFO Michael Casamento to step down, with Steve Sugar joining as CFO next week
Nov 5, 2025, 10:30 PM
Amcor reports Q1 FY 2026 results
AMCR
Earnings
Guidance Update
CFO Change
  • Adjusted EPS of $0.193 (+18% YoY) topped the midpoint of guidance, driven by disciplined cost performance and early synergy gains.
  • Delivered $38 M in Q1 synergies, secured > $70 M in annualized revenue synergies and have a clear line of sight to $260 M in Fiscal 2026 benefits.
  • Reaffirmed Fiscal 2026 guidance with EPS of $0.80–$0.83 (+12–17% YoY) and free cash flow of $1.8–$1.9 B, not dependent on macro improvements.
  • Agreed to sell two non-core businesses for ~$100 M proceeds and increased the quarterly dividend to $0.13 per share.
  • Announced CFO Michael Casamento’s departure; Steve Sugar to join as CFO next week.
Nov 5, 2025, 10:30 PM
Amcor reports Q1 2026 results
AMCR
Earnings
Guidance Update
CFO Change
  • Q1 adjusted EPS of $0.193 (+18%) on a comparable basis; EBIT $687 million (+4%) with a 12% margin (+110 bps); volumes down ~2% excluding non-core North American beverage.
  • Delivered $38 million of synergies in Q1; running rate supports at least $260 million in fiscal 2026 and $650 million through fiscal 2028.
  • Reaffirmed fiscal 2026 guidance: adjusted EPS $0.80–$0.83, free cash flow $1.8–$1.9 billion; Q2 EPS outlook $0.16–$0.18.
  • CFO Michael Casamento to step down after this call, transitioning to an advisory role; Steve Scherger joins as CFO next week.
  • Board approved a quarterly dividend increase to $0.13 per share.
Nov 5, 2025, 10:30 PM
Amcor reports Q1 FY26 results and reaffirms outlook
AMCR
Earnings
Guidance Update
M&A
  • Amcor reported Q1 net sales of $5,745 million (up 68% cc), adjusted EBITDA of $909 million (+92% cc) and adjusted EPS of 19.3 cps (+18% cc); GAAP net income was $262 million and the quarterly dividend was raised to 13.0 cps.
  • The Berry Global acquisition completed April 30, 2025, delivered approximately $38 million of synergies in the quarter, with integration on track for at least $260 million in FY26 and $650 million by FY28.
  • Amcor reaffirmed its FY26 guidance of adjusted EPS of $0.80–$0.83 per share (12–17% cc growth) and free cash flow of $1.8–$1.9 billion.
Nov 5, 2025, 9:20 PM
Amcor reports Q1 FY26 results and reaffirms guidance
AMCR
Earnings
Guidance Update
Dividends
  • Net sales of $5,745 million (up 68% ex-currency) and adjusted EPS of 19.3 cps (up 18% ex-currency) in the first quarter of fiscal 2026.
  • Adjusted EBITDA reached $909 million (up 92% ex-currency) and adjusted EBIT was $687 million (up 85% ex-currency); realized approximately $38 million of acquisition synergies.
  • Quarterly dividend increased to 13.0 cents per share, reflecting confidence in free cash flow generation.
  • Fiscal 2026 outlook reaffirmed: adjusted EPS of 80–83 cps and free cash flow of $1.8–1.9 billion.
Nov 5, 2025, 9:10 PM
Amcor provides pro forma income statement for Berry Global merger
AMCR
M&A
  • On April 30, 2025, Amcor plc completed its merger with Berry Global Group, Inc., making Berry a wholly owned subsidiary of Amcor.
  • This Form 8-K furnishes the unaudited pro forma condensed combined statement of income for the fiscal year ended June 30, 2025, reflecting the merger.
  • No pro forma balance sheet is included, as the merger is already reflected in Amcor’s audited consolidated balance sheets in its FY2025 10-K filed August 15, 2025.
Oct 2, 2025, 8:05 PM
Beyond Air expands global LungFit PH distribution network
AMCR
New Projects/Investments
  • Beyond Air has signed new LungFit PH distribution agreements in Japan, South Korea, Costa Rica, Guatemala, Panama, and El Salvador, bringing its total international coverage to 34 countries with a combined population of 2.7 billion.
  • The Japan partnership is with AMCO Incorporated, a leading distributor of medical devices in Japan for over 70 years.
  • LungFit PH is a tankless nitric oxide generator approved for commercial use in the U.S., European Union, and several other markets, streamlining hospital operations by eliminating high-pressure cylinders.
  • Hospital tender submissions are underway in multiple regions, while the company awaits regulatory approvals in others to drive further adoption.
Aug 20, 2025, 12:00 PM
Amcor reports Q4 2025 results and Berry integration progress
AMCR
Earnings
M&A
Guidance Update
  • Completed Berry Global acquisition integration in 100 days; targeting $650 m total synergies by FY 2028, including $260 m in FY 2026, underpinning 12–17% EPS growth and doubling free cash flow to €1.8–1.9 bn
  • Q4 combined net sales growth driven by Berry: flexibles net sales +18% CC with adjusted EBIT €450 m (14.1% margin) and rigid net sales +121% CC with EBIT margin 10.9%; volumes down ~1.7% led by North America
  • North America beverage business saw operational challenges (higher labor, freight costs, and waste) causing a ~$20 m EBIT decline; now run as a standalone unit with focused management
  • FY 2026 guidance assumes flat volumes, adjusted EPS $0.80–0.83, Q1 EPS $0.18–0.20, capex $850–900 m, net interest $570–600 m, and leverage reducing to 3.1–3.2x, excluding asset sale proceeds
Aug 14, 2025, 6:05 PM

Recent SEC filings and earnings call transcripts for AMCR.

No recent filings or transcripts found for AMCR.